Expression of Ets-related Transcription Factors and Matrix Metalloproteinase Genes in Human Breast Cancer Cells (original) (raw)
References
Wasylyk B, Hahn SL, Giovane A: The Ets family of transcription factors. Eur J Biochem 211: 7–18, 1993 ArticleCASPubMed Google Scholar
Shimizu K, Ichikawa H, Tojo A, Kaneko Y, Maseki N, Hayashi Y, Ohira M, Asano S, Ohki M: An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. Proc Natl Acad Sci USA 90: 10280–10284, 1993 CASPubMed Google Scholar
Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G: Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359: 162–165, 1992 ArticleCASPubMed Google Scholar
Ohyashiki K, Ohyashiki JH, Tauchi T, Iwabuchi H, Iwabuchi A, Toyama K: ETS1 gene in myelodysplastic syndrome with chromosome change at 11q23. Cancer Genet Cytogenet 45: 73–80, 1990 ArticleCASPubMed Google Scholar
Trimble MS, Xin JH, Guy CT, Muller WJ, Hassell JA: PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene 8: 3037–3042, 1993 CASPubMed Google Scholar
Chang CH, Scott GK, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, Benz CC: ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis. Oncogene 14: 1617–1622, 1997 CASPubMed Google Scholar
Monte D, Coutte L, Baert JL, Angeli I, Stehelin D, de Launoit Y: Molecular characterization of the ets-related human transcription factor ER81. Oncogene 11: 771–779, 1995 CASPubMed Google Scholar
Baert JL, Monte D, Musgrove EA, Albagli O, Sutherland RL, de Launoit Y: Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells. Int J Cancer 70: 590–597, 1997 ArticleCASPubMed Google Scholar
Higashino F, Yoshida T, Noumi M, Seiki M, Fujinaga K: Ets-related protein E1AF can activate three different matrix metalloproteinase gene promoters. Oncogene 10: 1461–1463, 1995 CASPubMed Google Scholar
Kaya M, Yoshida K, Higashino F, Mitaka T, Ishii S, Fujinaga K: A single ets-related transcription factor, ElAF, confers invasive phenotype on human cancer cells. Oncogene 12: 221–227, 1996 CASPubMed Google Scholar
Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S, Pozzatti RO: Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res 52: 4942–4947, 1992 CASPubMed Google Scholar
Denhardt DT, Greenberg A, Egan S, Hamilton R, Wright J: Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras transformed murine fibroblasts. Oncogene 2: 55–59, 1987 CASPubMed Google Scholar
Archbarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, Goltzman D, Rabbani SA: Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 54: 2372–2377, 1994 Google Scholar
Liotta LA, Tryggvason K, Garbisa S, Hart IR, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67–68, 1980 ArticleCASPubMed Google Scholar
Stearns M, Wang M: Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMPS 1 and 2) levels in noninvasive and metastatic PC-3 clones: Effects taxol Oncol Res 6: 195–201, 1994 CAS Google Scholar
Brown P, Bloxidge R, Anderson E, Howlett AR: Expression of activated gelatinase in human breast carcinoma. Clin Exp Metast 11: 183–189, 1993 ArticleCAS Google Scholar
Stearns M, Wang M: Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 53: 878–883, 1993 CASPubMed Google Scholar
Levy AT, Cioce V, Sobel ME, Garbisa S, Grignioni WF, Liotta LA, Stetler-Stevenson WG: Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 51: 439–444, 1998 Google Scholar
Autio-Harmanian H, Karttunen T, Hurskainen T, Hoyhtya M, Kauppila A, Tryggvason K: Expression of 72 kDa Type IV collagenase (gelatinase A) in benign and malignant ovarian tumours. Lab Invest 69: 312–321, 1993 Google Scholar
Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H, Dumont P, Eber M, Abecassis J: Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 48: 550–556, 1991 CASPubMed Google Scholar
Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, BalkwilI F: Levels of matrix metalloproteinase in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365–5369, 1993 CASPubMed Google Scholar
Matrisian LM: Matrix metalloproteinase gene expression. Ann NY Acad Sci 91: 10129–10133, 1994 Google Scholar
Edwards DH, Rocheleau H, Sharma RR, Wills AJ, Cowie A, Hassell JA, Heath JK: Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim Biophys Acta 1171: 41–55, 1992 CASPubMed Google Scholar
Nerlov C, Rorth P, Blasi F, Johnsen M: Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6: 1583–1592, 1991 CASPubMed Google Scholar
Habelhah H, Okada F, Kobayashi M, Nakai K, Choi S, Hamada J, Moriuchi T, Kaya M, Yoshida K, Fujinaga K, Hosokawa M: Increased ElAF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression. Oncogene 18: 1771–1776, 1999 ArticleCASPubMed Google Scholar
Sasaki A, Boyce BF, Story B, Wright KR, Chapman M, Boyce R, Mundy GR, Yoneda T: Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 55: 3551–3557, 1995 CASPubMed Google Scholar
Angel P, Baumann I, Stein B, DeLuis H, Rahmdorf HJ, Herrlich P: 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5_ flanking region. Mol Cell Biol 7: 2256–2266, 1987 CASPubMed Google Scholar
Maniatus T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989 Google Scholar
Heussen C, Dowdle EB: Electrophoretic analysis of plasm inogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102: 196–202, 1980 ArticleCASPubMed Google Scholar
Gilles C, Polette M, Birembaut P, Brunner N, Thompson EW: Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines. Clin Exp Metast 15: 519–526, 1997 Google Scholar
Stacey KJ, Fowles LF, Colman MS, Ostrowski MC, Hume DA: Regulation of urokinase-type plasminogen activator gene transcription by Macrophage Colony-Stimulating Factor Mol Cell Biol 15: 3430–3441, 1995 CAS Google Scholar
Delannoy-Courdent A, Mattot V, Fafeur V, Fauquette W, Pollet I, Calmels T, Vercamer C, Boilly B, Vandenbunder B, Desbiens X: The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J Cell Sci 111: 1521–1534, 1998 CASPubMed Google Scholar
Nakada M, Yamashita J, Okada Y, Sato H: Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors. J Neuropathol Exp Neurol 58: 329–334, 1999 CASPubMed Google Scholar
Kitange G, Shibata S, Tokunaga Y, Yagi N, Yasunaga A, Kishikawa M, Naito S: Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. Lab Invest 79: 407–416, 1999 CASPubMed Google Scholar